{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:33:32Z","timestamp":1791484412406,"version":"4.3.4"},"reference-count":97,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.psc.2024.09.004","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T10:55:33Z","timestamp":1728471333000},"page":"203-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of CBGTC Synaptic Neurotransmission in the Pathophysiology of Tics"],"prefix":"10.1016","volume":"48","author":[{"given":"Harvey S.","family":"Singer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Pellicciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psc.2024.09.004_bib1","series-title":"Tourette syndrome","first-page":"231","article-title":"Tourette syndrome: circuits and neurotransmitters","author":"Singer","year":"2022"},{"issue":"7","key":"10.1016\/j.psc.2024.09.004_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12070880","article-title":"A\u00a0pilot study on plasma and urine neurotransmitter levels in children with tic disorders","volume":"12","author":"Qian","year":"2022","journal-title":"Brain Sci"},{"issue":"4","key":"10.1016\/j.psc.2024.09.004_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ana.410120408","article-title":"Dopaminergic dsyfunction in Tourette syndrome","volume":"12","author":"Singer","year":"1982","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.psc.2024.09.004_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ana.410060109","article-title":"Biogenic amine metabolism in Tourette syndrome","volume":"6","author":"Butler","year":"1979","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/archpsyc.1978.01770260123015","article-title":"Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration","volume":"35","author":"Cohen","year":"1978","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2024.09.004_bib6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004583-198807000-00004","article-title":"Tourette's syndrome: clinical and neurochemical correlates","volume":"27","author":"Riddle","year":"1988","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1542\/pir.2023-006014","article-title":"Tourette syndrome and tic disorders","volume":"45","author":"Trau","year":"2024","journal-title":"Pediatr Rev"},{"issue":"4","key":"10.1016\/j.psc.2024.09.004_bib8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/acschemneuro.7b00460","article-title":"Update on the pharmacological treatment of tics with dopamine-modulating agents","volume":"9","author":"Mogwitz","year":"2018","journal-title":"ACS Chem Neurosci"},{"issue":"18","key":"10.1016\/j.psc.2024.09.004_bib9","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1080\/14656566.2016.1258063","article-title":"Dopamine depleters in the treatment of hyperkinetic movement disorders","volume":"17","author":"Jankovic","year":"2016","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"10.1016\/j.psc.2024.09.004_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/070674379003500305","article-title":"A\u00a0case of Tourette syndrome developing during haloperidol treatment","volume":"35","author":"Karagianis","year":"1990","journal-title":"Can J Psychiatry"},{"issue":"10","key":"10.1016\/j.psc.2024.09.004_bib11","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1212\/WNL.28.10.1064","article-title":"Gilles de la Tourette syndrome after long-term chlorpromazine therapy","volume":"28","author":"Klawans","year":"1978","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.psc.2024.09.004_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00702-020-02289-6","article-title":"Altered urinary tetrahydroisoquinoline derivatives in patients with Tourette syndrome: reflection of dopaminergic hyperactivity?","volume":"128","author":"Capetian","year":"2021","journal-title":"J\u00a0Neural Transm"},{"issue":"10","key":"10.1016\/j.psc.2024.09.004_bib13","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/dmcn.14613","article-title":"Anti-dopamine D2 receptor antibodies in chronic tic disorders","volume":"62","author":"Addabbo","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"10","key":"10.1016\/j.psc.2024.09.004_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci7100134","article-title":"Progress in genetic studies of tourette's syndrome","volume":"7","author":"Qi","year":"2017","journal-title":"Brain Sci"},{"issue":"8","key":"10.1016\/j.psc.2024.09.004_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0006-3223(94)00161-U","volume":"37","author":"Brett","year":"1995","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2024.09.004_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pediatrneurol.2005.05.005","article-title":"Dopamine receptor D2 gene polymorphisms are associated in Taiwanese children with Tourette syndrome","volume":"33","author":"Lee","year":"2005","journal-title":"Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.psc.2024.09.004_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ajmg.1320540311","article-title":"Association analysis of the dopamine D2 receptor gene in Tourette's syndrome using the haplotype relative risk method","volume":"54","author":"N\u00f6then","year":"1994","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.psc.2024.09.004_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/(SICI)1096-8628(19960531)67:3<301::AID-AJMG6>3.0.CO;2-P","article-title":"No evidence for a major gene effect of the dopamine D4 receptor gene in the susceptibility to Gilles de la Tourette syndrome in five Canadian families","volume":"67","author":"Barr","year":"1996","journal-title":"Am J Med Genet"},{"issue":"7","key":"10.1016\/j.psc.2024.09.004_bib19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0006-3223(94)00311-P","article-title":"No association of a tyrosine hydroxylase gene tetranucleotide repeat polymorphism in autism, Tourette syndrome, or ADHD","volume":"37","author":"Comings","year":"1995","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2024.09.004_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.mp.4001411","article-title":"Tourette syndrome and dopaminergic genes: a family-based association study in the French Canadian founder population","volume":"9","author":"D\u00edaz-Anzald\u00faa","year":"2004","journal-title":"Mol Psychiatry"},{"issue":"7","key":"10.1016\/j.psc.2024.09.004_bib21","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/ajmg.b.30517","article-title":"Dopaminergic candidate genes in Tourette syndrome: association between tic severity and 3' UTR polymorphism of the dopamine transporter gene","volume":"144B","author":"Tarnok","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1\u20132","key":"10.1016\/j.psc.2024.09.004_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jns.2007.01.069","article-title":"Frontal dopaminergic abnormality in Tourette syndrome: a postmortem analysis","volume":"255","author":"Yoon","year":"2007","journal-title":"J\u00a0Neurol Sci"},{"issue":"10","key":"10.1016\/j.psc.2024.09.004_bib23","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1093\/brain\/awad142","article-title":"Deep brain stimulation alleviates tics in Tourette syndrome via striatal dopamine transmission","volume":"146","author":"Rusheen","year":"2023","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/1574885514666191121143930","article-title":"The pathophysiology of tics; an evolving story","volume":"15","author":"Singer","year":"2020","journal-title":"Curr Drug Ther"},{"issue":"4","key":"10.1016\/j.psc.2024.09.004_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/(SICI)1096-8628(19990820)88:4<437::AID-AJMG24>3.0.CO;2-E","article-title":"Genome scan for linkage to Gilles de la Tourette syndrome","volume":"88","author":"Barr","year":"1999","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/YPG.0b013e328341a307","article-title":"Genetic and functional studies of a missense variant in a glutamate transporter, SLC1A3, in Tourette syndrome","volume":"21","author":"Adamczyk","year":"2011","journal-title":"Psychiatr Genet"},{"issue":"5","key":"10.1016\/j.psc.2024.09.004_bib27","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s11064-019-02739-y","article-title":"Increase in glutamatergic terminals in the striatum following dopamine depletion in a rat model of Parkinson\u2019s disease","volume":"44","author":"Zheng","year":"2019","journal-title":"Neurochem Res"},{"key":"10.1016\/j.psc.2024.09.004_bib28","first-page":"123","article-title":"Postmortem analysis of subcortical monoamines and amino acids in Tourette syndrome","volume":"58","author":"Anderson","year":"1992","journal-title":"Adv Neurol"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s43657-022-00064-z","article-title":"Cross-sectional exploration of the relationship between glutamate abnormalities and tic disorder severity using proton magnetic resonance spectroscopy","volume":"3","author":"Hao","year":"2023","journal-title":"Phenomics"},{"key":"10.1016\/j.psc.2024.09.004_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pscychresns.2017.12.005","article-title":"GABA and glutamate in children with Tourette syndrome: a","volume":"273","author":"Mahone","year":"2018","journal-title":"Psychiatry Res Neuroimaging"},{"issue":"3","key":"10.1016\/j.psc.2024.09.004_bib31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/mrm.1213","article-title":"In\u00a0vivo 1H NMR spectroscopy of the human brain at 7 T","volume":"46","author":"Tk\u00e1c","year":"2001","journal-title":"Magn Reson Med"},{"issue":"6","key":"10.1016\/j.psc.2024.09.004_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.pediatrneurol.2015.02.002","article-title":"Efficacy of glutamate modulators in tic suppression: a double-blind, randomized control trial of D-serine and riluzole in tourette syndrome","volume":"52","author":"Lemmon","year":"2015","journal-title":"Pediatr Neurol"},{"issue":"Pt 2","key":"10.1016\/j.psc.2024.09.004_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/brain\/awu338","article-title":"Alterations in structural connectivity may contribute both to the occurrence of tics in Gilles de la Tourette syndrome and to their subsequent control","volume":"138","author":"Draper","year":"2015","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.psc.2024.09.004_bib34","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1523\/JNEUROSCI.3894-04.2005","article-title":"Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation","volume":"25","author":"Faure","year":"2005","journal-title":"J\u00a0Neurosci"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.neuroscience.2010.03.047","article-title":"Dopamine agonists increase perseverative instrumental responses but do not restore habit formation in a rat model of Parkinsonism","volume":"168","author":"Faure","year":"2010","journal-title":"Neuroscience"},{"issue":"18","key":"10.1016\/j.psc.2024.09.004_bib36","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1523\/JNEUROSCI.2717-15.2016","article-title":"Striatopallidal neuron NMDA receptors control synaptic connectivity, locomotor, and goal-directed behaviors","volume":"36","author":"Lambot","year":"2016","journal-title":"J\u00a0Neurosci"},{"issue":"12","key":"10.1016\/j.psc.2024.09.004_bib37","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1523\/JNEUROSCI.19-12-05044.1999","article-title":"OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons","volume":"19","author":"Campbell","year":"1999","journal-title":"J\u00a0Neurosci"},{"issue":"6","key":"10.1016\/j.psc.2024.09.004_bib38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.mp.4001144","article-title":"A\u00a0transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry","volume":"7","author":"Nordstrom","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.psc.2024.09.004_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainres.2015.09.032","article-title":"\"Hyperglutamatergic cortico-striato-thalamo-cortical circuit\" breaker drugs alleviate tics in a transgenic circuit model of Tourette\u05f3s syndrome","volume":"1629","author":"Nordstrom","year":"2015","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.psc.2024.09.004_bib40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S0317167100025129","article-title":"Seven cases of Gilles de la tourette's syndrome: partial relief with clonazepam: a pilot study","volume":"4","author":"Gonce","year":"1977","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"10.1016\/j.psc.2024.09.004_bib41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/088307389901400508","article-title":"Tics in Tourette syndrome: new treatment options","volume":"14","author":"Awaad","year":"1999","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.psc.2024.09.004_bib42","series-title":"Gilles de la Tourette syndrome","first-page":"558","author":"Shapiro","year":"1988"},{"issue":"5","key":"10.1016\/j.psc.2024.09.004_bib43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1212\/WNL.56.5.599","article-title":"Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial","volume":"56","author":"Singer","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.psc.2024.09.004_bib44","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/ene.14107","article-title":"Safety and efficacy of taurine as an add-on treatment for tics in youngsters","volume":"27","author":"Ding","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.psc.2024.09.004_bib45","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.brainres.2011.01.026","article-title":"GABA- and acetylcholine-related gene expression in blood correlate with tic severity and microarray evidence for alternative splicing in Tourette syndrome: a pilot study","volume":"1381","author":"Tian","year":"2011","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.psc.2024.09.004_bib46","first-page":"156","article-title":"Tourette syndrome: bridging the gap between genetics and biology","volume":"1","author":"Richer","year":"2015","journal-title":"Mol Neuropsychiatry"},{"issue":"37","key":"10.1016\/j.psc.2024.09.004_bib47","doi-asserted-by":"crossref","first-page":"13307","DOI":"10.1073\/pnas.0502624102","article-title":"Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome","volume":"102","author":"Kalanithi","year":"2005","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A."},{"issue":"3","key":"10.1016\/j.psc.2024.09.004_bib48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cne.22206","article-title":"Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome","volume":"518","author":"Kataoka","year":"2010","journal-title":"J\u00a0Comp Neurol"},{"issue":"4","key":"10.1016\/j.psc.2024.09.004_bib49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/ana.410300408","article-title":"Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome","volume":"30","author":"Singer","year":"1991","journal-title":"Ann Neurol"},{"issue":"19","key":"10.1016\/j.psc.2024.09.004_bib50","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.cub.2014.08.038","article-title":"Increased GABA contributes to enhanced control over motor excitability in Tourette syndrome","volume":"24","author":"Draper","year":"2014","journal-title":"Curr Biol"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib51","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1152\/jn.00060.2015","article-title":"Reduced GABAergic inhibition and abnormal sensory symptoms in children with Tourette syndrome","volume":"114","author":"Puts","year":"2015","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.psc.2024.09.004_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pediatrneurol.2016.08.017","article-title":"Decreased anterior cingulate cortex \u03b3-aminobutyric acid in youth with tourette's disorder","volume":"65","author":"Freed","year":"2016","journal-title":"Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.psc.2024.09.004_bib53","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/mds.28868","article-title":"Frequency and intensity of premonitory urges-to-tic in tourette syndrome is associated with supplementary motor area GABA+ levels","volume":"37","author":"He","year":"2022","journal-title":"Mov Disord"},{"issue":"Pt 6","key":"10.1016\/j.psc.2024.09.004_bib54","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/brain\/aws104","article-title":"Widespread abnormality of the \u03b3-aminobutyric acid-ergic system in Tourette syndrome","volume":"135","author":"Lerner","year":"2012","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.psc.2024.09.004_bib55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jpsychores.2009.07.014","article-title":"Transcranial magnetic stimulation in Gilles de la Tourette syndrome","volume":"67","author":"Orth","year":"2009","journal-title":"J\u00a0Psychosom Res"},{"issue":"Pt 2","key":"10.1016\/j.psc.2024.09.004_bib56","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/brain\/awp299","article-title":"Altered modulation of intracortical excitability during movement preparation in Gilles de la Tourette syndrome","volume":"133","author":"Heise","year":"2010","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.psc.2024.09.004_bib57","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/npp.2017.178","article-title":"Parvalbumin interneurons of the mouse nucleus accumbens are required for amphetamine-induced locomotor sensitization and conditioned place preference","volume":"43","author":"Wang","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.psc.2024.09.004_bib58","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/cercor\/bhn214","article-title":"Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum","volume":"19","author":"Worbe","year":"2009","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.psc.2024.09.004_bib59","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fnsys.2013.00050","article-title":"Motor tics evoked by striatal disinhibition in the rat","volume":"7","author":"Bronfeld","year":"2013","journal-title":"Front Syst Neurosci"},{"issue":"41","key":"10.1016\/j.psc.2024.09.004_bib60","doi-asserted-by":"crossref","first-page":"15254","DOI":"10.1073\/pnas.0601758103","article-title":"Disrupted motor learning and long-term synaptic plasticity in mice lacking NMDAR1 in the striatum","volume":"103","author":"Dang","year":"2006","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib61","article-title":"The \u03b16 GABA","volume":"11","author":"Cadeddu","year":"2021","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.psc.2024.09.004_bib62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/WNF.0000000000000056","article-title":"Bupropion XL-induced motor and vocal tics","volume":"37","author":"Kayhan","year":"2014","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"10.1016\/j.psc.2024.09.004_bib63","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/mdc3.13207","article-title":"Pilot study to evaluate pimavanserin for the treatment of motor and behavioral symptoms of tourette syndrome","volume":"8","author":"Billnitzer","year":"2021","journal-title":"Mov Disord Clin Pract"},{"issue":"7","key":"10.1016\/j.psc.2024.09.004_bib64","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.mp.4002004","article-title":"Role of the novel tryptophan hydroxylase-2 gene in Tourette syndrome","volume":"12","author":"M\u00f6ssner","year":"2007","journal-title":"Mol Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2024.09.004_bib65","first-page":"646","article-title":"[Association of serotonin transporter linked polymorphic region 44\u00a0bp variable number of tandem repeat polymorphism with Tourette syndrome]","volume":"31","author":"Zhang","year":"2014","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"issue":"10","key":"10.1016\/j.psc.2024.09.004_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/genes12101510","article-title":"EWAS of monozygotic twins implicate a role of mTOR pathway in pathogenesis of tic spectrum disorder","volume":"12","author":"Hildonen","year":"2021","journal-title":"Genes"},{"issue":"19","key":"10.1016\/j.psc.2024.09.004_bib67","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1073\/pnas.1522754113","article-title":"Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids","volume":"113","author":"Geddes","year":"2016","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A."},{"issue":"4","key":"10.1016\/j.psc.2024.09.004_bib68","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ana.410270415","article-title":"Tourette's syndrome: a neurochemical analysis of postmortem cortical brain tissue","volume":"27","author":"Singer","year":"1990","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.psc.2024.09.004_bib69","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.neuron.2014.02.010","article-title":"Dorsal raphe neurons signal reward through 5-HT and glutamate","volume":"81","author":"Liu","year":"2014","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.psc.2024.09.004_bib70","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1176\/appi.ajp.161.11.2028","article-title":"Altered interhemispheric connectivity in individuals with Tourette's disorder","volume":"161","author":"Plessen","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2024.09.004_bib71","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1212\/WNL.51.4.1069","article-title":"Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity","volume":"51","author":"Heinz","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.psc.2024.09.004_bib72","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s41598-018-37710-4","article-title":"Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder","volume":"9","author":"M\u00fcller-Vahl","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib73","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S1461145706006559","article-title":"Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome","volume":"10","author":"Haugb\u00f8l","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"issue":"15","key":"10.1016\/j.psc.2024.09.004_bib74","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/mds.21712","article-title":"Abnormal brain tryptophan metabolism and clinical correlates in Tourette syndrome","volume":"22","author":"Behen","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2024.09.004_bib75","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2013.01.007","article-title":"Support for 5-HT2C receptor functional selectivity in\u00a0vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model","volume":"70","author":"Canal","year":"2013","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.psc.2024.09.004_bib76","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1212\/WNL.32.11.1315","article-title":"Cholinergic mechanisms in Tourette syndrome","volume":"32","author":"Tanner","year":"1982","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.psc.2024.09.004_bib77","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archneur.1984.04050180078022","article-title":"CSF cholinesterase activity in Gilles de la Tourette's syndrome","volume":"41","author":"Singer","year":"1984","journal-title":"Arch Neurol"},{"issue":"23","key":"10.1016\/j.psc.2024.09.004_bib78","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJM198006053022313","article-title":"Cholinergic treatment in the Tourette syndrome","volume":"302","author":"Barbeau","year":"1980","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib79","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1176\/ajp.138.2.240","article-title":"Physostigmine in Tourette syndrome: evidence for cholinergic underactivity","volume":"138","author":"Stahl","year":"1981","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/cap.2000.10.59","article-title":"Mecamylamine in Tourette's syndrome: a two-year retrospective case study","volume":"10","author":"Silver","year":"2000","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib81","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nurx.2006.01.009","article-title":"Contemporary assessment and pharmacotherapy of Tourette syndrome","volume":"3","author":"Scahill","year":"2006","journal-title":"NeuroRx"},{"issue":"6","key":"10.1016\/j.psc.2024.09.004_bib82","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.tins.2016.03.004","article-title":"Prefrontal cortical opioids and dysregulated motivation: a network hypothesis","volume":"39","author":"Baldo","year":"2016","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.psc.2024.09.004_bib83","first-page":"9","article-title":"Association of rare genetic variants in opioid receptors with tourette syndrome","author":"Depienne","year":"2019","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib84","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0022-510X(86)90097-3","article-title":"Gilles de la Tourette's syndrome. A postmortem neuropathological and immunohistochemical study","volume":"75","author":"Haber","year":"1986","journal-title":"J\u00a0Neurol Sci"},{"issue":"24","key":"10.1016\/j.psc.2024.09.004_bib85","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/0024-3205(88)90575-9","article-title":"Elevated CSF dynorphin A [1-8] in Tourette's syndrome","volume":"43","author":"Leckman","year":"1988","journal-title":"Life Sci"},{"issue":"11","key":"10.1016\/j.psc.2024.09.004_bib86","first-page":"1527","article-title":"Cerebrospinal fluid dynorphin A[1-8] and beta-endorphin levels in Tourette's syndrome are unaltered","volume":"45","author":"van Wattum","year":"1999","journal-title":"Biol Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.psc.2024.09.004_bib87","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/00207458708987115","article-title":"Naloxone abolishes obsessive-compulsive behavior in Tourette's syndrome","volume":"35","author":"Sandyk","year":"1987","journal-title":"Int J Neurosci"},{"issue":"1","key":"10.1016\/j.psc.2024.09.004_bib88","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.410300105","article-title":"A\u00a0controlled trial of propoxyphene and naltrexone in patients with Tourette's syndrome","volume":"30","author":"Kurlan","year":"1991","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.psc.2024.09.004_bib89","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/1531-8257(200011)15:6<1252::AID-MDS1030>3.0.CO;2-I","article-title":"Patterns of response to acute naloxone infusion in Tourette's syndrome","volume":"15","author":"van Wattum","year":"2000","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.psc.2024.09.004_bib90","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.2042-7158.1975.tb09387.x","article-title":"Serotonergic involvement with the stereotypy\/catalepsy induced by morphine-like agents in the rat","volume":"27","author":"Costall","year":"1975","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"18","key":"10.1016\/j.psc.2024.09.004_bib91","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/0024-3205(85)90293-0","article-title":"Simultaneous catalepsy and apomorphine-induced stereotypic behavior in mice","volume":"37","author":"Yurek","year":"1985","journal-title":"Life Sci"},{"key":"10.1016\/j.psc.2024.09.004_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112317","article-title":"Cortical endogenous opioids and their role in facilitating repetitive behaviors in deer mice","volume":"379","author":"Augustine","year":"2020","journal-title":"Behav Brain Res"},{"issue":"2","key":"10.1016\/j.psc.2024.09.004_bib93","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbr.2004.08.003","article-title":"Striatal opioid peptide content in an animal model of spontaneous stereotypic behavior","volume":"157","author":"Presti","year":"2005","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.psc.2024.09.004_bib94","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0022-510X(94)00211-6","article-title":"Second messenger systems in Tourette's syndrome","volume":"128","author":"Singer","year":"1995","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.psc.2024.09.004_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109477","article-title":"ATP-mediated signalling in the central synapses","volume":"229","author":"Lalo","year":"2023","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.psc.2024.09.004_bib96","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2174\/187152711798072329","article-title":"Nitric oxide modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders","volume":"10","author":"Pierucci","year":"2011","journal-title":"CNS Neurol Disord: Drug Targets"},{"key":"10.1016\/j.psc.2024.09.004_bib97","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/bs.mie.2014.11.025","article-title":"Role of hydrogen sulfide in brain synaptic remodeling","volume":"555","author":"Kamat","year":"2015","journal-title":"Methods Enzymol"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X24000844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X24000844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T17:03:44Z","timestamp":1749488624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X24000844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0193953X24000844"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2024.09.004","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of CBGTC Synaptic Neurotransmission in the Pathophysiology of Tics","name":"articletitle","label":"Article Title"},{"value":"Psychiatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psc.2024.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}